On March 11, 2024, Kevin Guest, Chairman of the Board of Directors of USANA Health Sciences, Inc. (NYSE:USNA) sold 11,011 shares of the company's stock. This transaction has been filed with his SEC and is described in his SEC filing below.
Usana Health Sciences Inc is a company that develops and manufactures nutritional supplements, health foods, and personal care products sold directly to associates and preferred customers in the United States, Asia Pacific, and Europe.
Over the past year, Kevin Guest sold 11,011 shares but did not buy any shares in the company. This latest transaction continues the trend observed over the past year, with no insider buying and 28 insider selling for USANA Health Sciences.
On the day of the most recent insider sale, Usana Health Sciences Inc. stock was trading at $49, giving the company a market cap of $940,669,000. The company's price-to-earnings ratio of 14.82 is lower than the industry median of 18.205, and is also lower than the company's historical median price-to-earnings ratio.
With a price of $49 and a GF value of $59.63, Usana Health Sciences Inc.'s price to GF value ratio is 0.82, indicating the stock is moderately undervalued, according to GuruFocus Value.
GF Value is a proprietary intrinsic value estimate by GuruFocus and is calculated based on historical trading multiples, GuruFocus adjustment factors based on the company's past earnings and growth, and future performance estimates from Morningstar analysts .
Investors and analysts often monitor insider sales as they can get an insider's perspective on the value of a company's shares. While a single insider selling transaction may not be indicative of a company's future performance, trends in insider selling can indicate how insiders view a stock's valuation.
This article created by GuruFocus is intended to provide general insight and is not intended as financial advice. Our commentary is based on historical data and analyst forecasts using an unbiased methodology and is not intended to serve as specific investment guidance. It does not constitute a recommendation to buy or sell stocks, and does not take into account your individual investment objectives or financial situation. Our objective is to provide fundamental data-driven analysis over time. Please note that our analysis may not incorporate the latest announcements or qualitative information from price-sensitive companies. GuruFocus has no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
